» Articles » PMID: 23725096

COPD and Disease-specific Health Status in a Working Population

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2013 Jun 4
PMID 23725096
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It has been debated whether treatment should be started early in subjects with mild to moderate COPD. An impaired health status score was associated with a higher probability of being diagnosed with COPD as compared with undiagnosed COPD.

Purpose: To investigate the health status in a healthy working population, to determine reference scores for healthy non-smoking subjects, and to investigate the relationship between their health status and airflow limitation.

Methods: A total of 1333 healthy industrial workers aged ≥40 years performed spirometry and completed the St. George's Respiratory Questionnaire (SGRQ) and the COPD Assessment Test (CAT).

Results: The prevalence of COPD defined by the fixed ratio of the forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) was 10.9%, and the prevalence defined by the Lower Limit of Normal was 5.0%. All SGRQ and CAT scores were skewed to the milder end. In 512 non-smoking subjects with normal spirometry, the mean SGRQ score was 5.7, and the mean CAT score was 5.8. In 145 people with COPD defined by the fixed ratio, the mean SGRQ score was 7.9, with a zero score in 6.9% of the subjects. Using the CAT, the mean score was 7.3, with 7.6% of the scores being zero. The scores in patients identified using the Lower Limit of Normal approach were: SGRQ 8.4 (13.4% had a score of zero) and CAT 7.4 (13.4% had a score of zero). Although the 95th percentiles of the Total, Symptoms, Activity, and Impact scores of the SGRQ and CAT sores were 13.8, 34.0, 23.4, 7.2 and 13.6 in the 512 healthy non-smoking subjects, respectively, they were also distributed under their upper limits in over 80% of the COPD subjects.

Conclusion: The COPD-specific health status scores in a working population were good, even in those with spirometrically diagnosed COPD. All scores were widely distributed in both healthy non-smoking subjects and in subjects with COPD, and the score distribution overlapped remarkably between these two groups. This suggests that symptom-based methods are not suitable screening tools in a healthy general population.

Citing Articles

The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis.

Nakamura K, Fujita Y, Chen H, Somekawa K, Kashizaki F, Koizumi H Diseases. 2023; 11(4).

PMID: 37987263 PMC: 10660475. DOI: 10.3390/diseases11040152.


The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice.

Nishimura K, Kusunose M, Mori M, Shibayama A, Nakayasu K Diagnostics (Basel). 2023; 13(15).

PMID: 37568855 PMC: 10417120. DOI: 10.3390/diagnostics13152492.


Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.

Martinez F, Agusti A, Celli B, Han M, Allinson J, Bhatt S Am J Respir Crit Care Med. 2021; 205(3):275-287.

PMID: 34672872 PMC: 8886994. DOI: 10.1164/rccm.202107-1663SO.


Association between body mass index and patient-reported-outcome questionnaire scores (CAT™, ACT™, mMRC dyspnoea scale, IPAQ) in Ukraine, Kazakhstan and Azerbaijan: results of the CORE study.

Nugmanova D, Feshchenko Y, Iashyna L, Polianska M, Malynovska K, Stafeyeva I BMC Pulm Med. 2021; 21(1):192.

PMID: 34098922 PMC: 8182935. DOI: 10.1186/s12890-021-01542-2.


Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan - Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J).

Omori H, Higashi N, Nawa T, Fukui T, Kaise T, Suzuki T Int J Chron Obstruct Pulmon Dis. 2020; 15:3039-3050.

PMID: 33262583 PMC: 7696619. DOI: 10.2147/COPD.S272588.


References
1.
Mannino D, Gagnon R, Petty T, Lydick E . Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160(11):1683-9. DOI: 10.1001/archinte.160.11.1683. View

2.
Vestbo J, Hurd S, Agusti A, Jones P, Vogelmeier C, Anzueto A . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2012; 187(4):347-65. DOI: 10.1164/rccm.201204-0596PP. View

3.
Qaseem A, Snow V, Shekelle P, Sherif K, Wilt T, Weinberger S . Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007; 147(9):633-8. View

4.
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T . Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(3 Pt 1):785-90. DOI: 10.1164/ajrccm.157.3.9703055. View

5.
Rabe K, Wedzicha J . Controversies in treatment of chronic obstructive pulmonary disease. Lancet. 2011; 378(9795):1038-47. DOI: 10.1016/S0140-6736(11)61295-6. View